Been in touch with the company ...
“We have announced ethical approvals for the phase 2 trial in pancreatic cancer and all is in place for patient recruitment and screening. We will inform the market when the first patient in the trial has been dosed with the first dose of the study drug.’
All good ... a little more time
Fabulous buying opportunity ...
.
Valuation- Amplia is a sleeping giant, page-46
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.59M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 14.0¢ | $93.83K | 634.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 91379 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 272514 | 3 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |